These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 11136276

  • 1. Efficacy of parenteral methotrexate in refractory Crohn's disease.
    Chong RY, Hanauer SB, Cohen RD.
    Aliment Pharmacol Ther; 2001 Jan; 15(1):35-44. PubMed ID: 11136276
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA, McDonald JW, Feagan BG.
    Cochrane Database Syst Rev; 2003 Dec 12; (1):CD003459. PubMed ID: 12535475
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA, McDonald JW, Feagan BG.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD003459. PubMed ID: 15674908
    [Abstract] [Full Text] [Related]

  • 5. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb 25; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate for the treatment of refractory Crohn's disease.
    Lémann M, Chamiot-Prieur C, Mesnard B, Halphen M, Messing B, Rambaud JC, Gendre JP, Colombel JF, Modigliani R.
    Aliment Pharmacol Ther; 1996 Jun 25; 10(3):309-14. PubMed ID: 8791956
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate in refractory Crohn's disease.
    Vandeputte L, D'Haens G, Baert F, Rutgeerts P.
    Inflamm Bowel Dis; 1999 Feb 25; 5(1):11-5. PubMed ID: 10028444
    [Abstract] [Full Text] [Related]

  • 8. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

  • 9. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
    Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW.
    N Engl J Med; 2000 Jun 01; 342(22):1627-32. PubMed ID: 10833208
    [Abstract] [Full Text] [Related]

  • 10. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V, Macdonald JK, McDonald JW, Chande N.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006884. PubMed ID: 19821390
    [Abstract] [Full Text] [Related]

  • 11. [Drug treatment of Crohn's disease].
    van Deventer SJ, Tytgat GN.
    Ned Tijdschr Geneeskd; 1998 May 23; 142(21):1191-5. PubMed ID: 9627451
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
    Oren R, Moshkowitz M, Odes S, Becker S, Keter D, Pomeranz I, Shirin H, Reisfeld I, Broide E, Lavy A, Fich A, Eliakim R, Patz J, Villa Y, Arber N, Gilat T.
    Am J Gastroenterol; 1997 Dec 23; 92(12):2203-9. PubMed ID: 9399753
    [Abstract] [Full Text] [Related]

  • 13. Use of methotrexate in refractory Crohn's disease: the Edinburgh experience.
    Din S, Dahele A, Fennel J, Aitken S, Shand AG, Arnott ID, Satsangi J.
    Inflamm Bowel Dis; 2008 Jun 23; 14(6):756-62. PubMed ID: 18275071
    [Abstract] [Full Text] [Related]

  • 14. The safety and tolerability of methotrexate for treating patients with Crohn's disease.
    Chande N, Abdelgadir I, Gregor J.
    J Clin Gastroenterol; 2011 Aug 23; 45(7):599-601. PubMed ID: 21224737
    [Abstract] [Full Text] [Related]

  • 15. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study.
    Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G.
    Dig Liver Dis; 2003 Sep 23; 35(9):619-27. PubMed ID: 14563183
    [Abstract] [Full Text] [Related]

  • 16. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
    Arora S, Katkov W, Cooley J, Kemp JA, Johnston DE, Schapiro RH, Podolsky D.
    Hepatogastroenterology; 1999 Sep 23; 46(27):1724-9. PubMed ID: 10430331
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
    Turner D, Grossman AB, Rosh J, Kugathasan S, Gilman AR, Baldassano R, Griffiths AM.
    Am J Gastroenterol; 2007 Dec 23; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110
    [Abstract] [Full Text] [Related]

  • 18. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I, Faubion WA.
    Inflamm Bowel Dis; 2012 Aug 23; 18(8):1488-92. PubMed ID: 21882301
    [Abstract] [Full Text] [Related]

  • 19. [The efficacy and safety of methotrexate in refractory Crohn's disease].
    Xu P, He Y, Chen Y, Chao K, Chen B, Mao R, Tang R, Zhu Z, Zeng Z, Chen M.
    Zhonghua Nei Ke Za Zhi; 2014 Mar 23; 53(3):188-92. PubMed ID: 24767205
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate in patients with Crohn's disease after 6-mercaptopurine.
    Mack DR, Young R, Kaufman SS, Ramey L, Vanderhoof JA.
    J Pediatr; 1998 May 23; 132(5):830-5. PubMed ID: 9602195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.